Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
Obes Facts ; 17(3): 286-295, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38569473

RESUMEN

INTRODUCTION: Medication-overuse headache (MOH) is a secondary chronic headache disorder that occurs in individuals with a pre-existing primary headache disorder, particularly migraine disorder. Obesity is often combined with chronic daily headaches and is considered a risk factor for the transformation of episodic headaches into chronic headaches. However, the association between obesity and MOH among individuals with migraine has rarely been studied. The present study explored the association between body mass index (BMI) and MOH in people living with migraine. METHODS: This cross-sectional study is a secondary analysis of data from the Survey of Fibromyalgia Comorbidity with Headache study. Migraine and MOH were diagnosed using the criteria of the International Classification of Headache Disorders, 3rd Edition. BMI (kg/m2) is calculated by dividing the weight (kg) by the square of the height (m). Multivariable logistic regression analysis was used to evaluate the association between BMI and MOH. RESULTS: A total of 2,251 individuals with migraine were included, of whom 8.7% (195/2,251) had a concomitant MOH. Multivariable logistic regression analysis, adjusted for age, sex, education level, headache duration, pain intensity, headache family history, chronic migraine, depression, anxiety, insomnia, and fibromyalgia, demonstrated there was an association between BMI (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.01-1.11; p = 0.031) and MOH. The results remained when the BMI was transformed into a category. Compared to individuals with Q2 (18.5 kg/m2 ≤ BMI ≤23.9 kg/m2), those with Q4 (BMI ≥28 kg/m2) had an adjusted OR for MOH of 1.81 (95% CI, 1.04-3.17; p = 0.037). In the subgroup analyses, BMI was associated with MOH among aged more than 50 years (OR, 1.13; 95%, 1.03-1.24), less than high school (OR, 1.08; 95%, 1.01-1.15), without depression (OR, 1.06; 95%, 1.01-1.12), and without anxiety (OR, 1.06; 95%, 1.01-1.12). An association between BMI and MOH was found in a sensitivity analysis that BMI was classified into four categories according to the World Health Organization guidelines. CONCLUSION: In this cross-sectional study, BMI was associated with MOH in Chinese individuals with migraine.


Asunto(s)
Índice de Masa Corporal , Cefaleas Secundarias , Trastornos Migrañosos , Obesidad , Humanos , Estudios Transversales , Trastornos Migrañosos/complicaciones , Trastornos Migrañosos/epidemiología , Masculino , Femenino , Adulto , Persona de Mediana Edad , Obesidad/complicaciones , Obesidad/epidemiología , Cefaleas Secundarias/epidemiología , Factores de Riesgo , Comorbilidad , Modelos Logísticos
2.
J Headache Pain ; 24(1): 119, 2023 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-37653478

RESUMEN

BACKGROUND: Headache disorders are widely prevalent and pose a considerable economic burden on individuals and society. Globally, misdiagnosis and inadequate treatment of primary headache disorders remain significant challenges, impeding the effective management of such conditions. Despite advancements in headache management over the last decade, a need for comprehensive evaluations of the status of primary headache disorders in China regarding diagnosis and preventative treatments persists. METHODS: In the present study, we analyzed the established queries in the Survey of Fibromyalgia Comorbidity with Headache (SEARCH), focusing on previous diagnoses and preventative treatment regimens for primary headache disorders. This cross-sectional study encompassed adults diagnosed with primary headache disorders who sought treatment at 23 hospitals across China between September 2020 to May 2021. RESULTS: The study comprised 2,868 participants who were systematically examined. Migraine and tension-type headaches (TTH) constituted a majority of the primary headache disorders, accounting for 74.1% (2,124/2,868) and 23.3% (668/2,868) of the participants, respectively. Medication overuse headache (MOH) affected 8.1% (231/2,868) of individuals with primary headache disorders. Over half of the individuals with primary headache disorders (56.6%, 1,624/2,868) remained undiagnosed. The previously correct diagnosis rates for migraine, TTH, TACs, and MOH were 27.3% (580/2,124), 8.1% (54/668), 23.2% (13/56), and 3.5% (8/231), respectively. The misdiagnosis of "Nervous headache" was found to be the most prevalent among individuals with migraine (9.9%, 211/2,124), TTH (10.0%, 67/668), trigeminal autonomic cephalalgias (TACs) (17.9%, 10/56), and other primary headache disorders (10.0%, 2/20) respectively. Only a minor proportion of individuals with migraine (16.5%, 77/468) and TTH (4.7%, 2/43) had received preventive medication before participating in the study. CONCLUSIONS: While there has been progress made in the rate of correct diagnosis of primary headache disorders in China compared to a decade ago, the prevalence of misdiagnosis and inadequate treatment of primary headaches remains a veritable issue. As such, focused efforts are essential to augment the diagnosis and preventive treatment measures related to primary headache disorders in the future.


Asunto(s)
Cefaleas Secundarias , Trastornos Migrañosos , Cefalea de Tipo Tensional , Cefalalgia Autónoma del Trigémino , Adulto , Humanos , Estudios Transversales , Cefalea , Cefalea de Tipo Tensional/diagnóstico , Cefalea de Tipo Tensional/tratamiento farmacológico , Cefalea de Tipo Tensional/epidemiología , China/epidemiología , Cefaleas Secundarias/diagnóstico , Cefaleas Secundarias/epidemiología , Cefaleas Secundarias/prevención & control
3.
Arq. neuropsiquiatr ; Arq. neuropsiquiatr;78(12): 778-782, Dec. 2020. tab
Artículo en Inglés | LILACS | ID: biblio-1142370

RESUMEN

ABSTRACT Background: Migraine is one of the most common disorders in neurological clinical practice and is part of the group of primary headaches. It often affects individuals in the age group of 25-55 years, when people are at their peak of economic productivity. Many patients ultimately overuse analgesics. Overuse is defined by the use of analgesics for at least 15 times a month - within a minimal three-month period. Impulsivity and migraine cause losses in the lives of individuals suffering from them, as they can compromise these individuals' social, emotional, and professional spheres. Regarding the professional sphere, it results in economic losses compared with the overall population. Objective: To investigate the presence of impulsive behavior in patients with migraine and with medication-overuse migraine. Methods: Cross-sectional study on 210 female and male patients; 140 were diagnosed with migraine according to criteria of the International Classification of Headache Disorders and were subdivided into two groups (70 patients each). One of these groups was composed of medication-overuse patients; the control group was composed of non-migraine patients (70 patients). All patients were evaluated with the Barratt Impulsivity Scale (BIS-11). Results: The group of migraine patients accounted for the highest impulsivity level, followed by the control group and, finally, by the medication-overuse group. However, these differences did not attain statistical significance. Conclusions: It was not possible to establish a clear connection between migraine and impulsive behavior. Association was higher among migraineurs without medication overuse.


RESUMO Introdução: A enxaqueca é uma das condições mais comuns na prática clínica neurológica, enquadrando-se no grupo das cefaleias primárias. Sua prevalência é maior na faixa etária de 25 a 55 anos, coincidindo com o pico da produtividade econômica. Muitos pacientes recorrem ao uso abusivo de analgésicos. O uso excessivo desses medicamentos é definido pela sua utilização por pelo menos 15 vezes ao mês, por um período de no mínimo três meses. A impulsividade e a enxaqueca causam prejuízos na vida dos indivíduos afetados, podendo comprometer os âmbitos social, emocional e profissional, resultando em um prejuízo monetário a esse grupo, em relação à população em geral. Objetivo: Investigar a presença de comportamento impulsivo em pacientes com enxaqueca com abuso de analgésico. Métodos: Estudo de corte transversal com 210 pacientes, homens e mulheres, sendo 140 com diagnóstico de enxaqueca segundo os critérios da Classificação Internacional das Cefaleias (IHCD-3), subdivididos em dois grupos de 70 pacientes cada, um composto por pacientes em uso excessivo de medicamentos, e um grupo controle composto por indivíduos sem enxaqueca. Todos os pacientes foram avaliados com a Escala de Impulsividade de Barratt - BIS 11. Resultados: O grupo com enxaqueca apresentou maior impulsividade, seguido do grupo controle e, por fim, o grupo com enxaqueca com abuso de medicamentos. No entanto, essas diferenças não atingiram significância estatística. Conclusão: Não foi possível encontrar relação direta entre a enxaqueca e comportamentos impulsivos. No entanto, esta relação foi maior entre os pacientes com enxaqueca sem abuso de analgésico.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Cefaleas Secundarias/epidemiología , Trastornos Migrañosos/tratamiento farmacológico , Trastornos Migrañosos/epidemiología , Prevalencia , Estudios Transversales , Uso Excesivo de Medicamentos Recetados , Analgésicos/efectos adversos , Conducta Impulsiva
4.
Clin Neurol Neurosurg ; 196: 105994, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32540713

RESUMEN

BACKGROUND: To date, the literature directly comparing the translabyrinthine approach and retrosigmoid approach in the operation of patients with vestibular schwannoma was limited. We aimed to evaluate postoperative complications between translabyrinthine approach and retrosigmoid approach for treating vestibular schwannoma patients. MATERIAL AND METHOD: Potential publications were selected from PubMed, Web of Science and Cochrane Library. Gray relevant studies were manually searched. We set the searching time spanning from the creation date of electronic engines to February 2020. STATA version 12.0 was exerted to process the pooled data. RESULTS: A total of 9 literature included in the study, involving 2429 patients, hails from the Germany, USA, Canada, Italy, and France. Of these 2429 patients with vestibular schwannoma, there were 1628 cases from the translabyrinthine approach group versus 801 cases from the retrosigmoid approach group. The results demonstrated that the translabyrinthine approach group was associated with a lower rate of tinnitus (OR = 2.687; 95 %CI, 1.167-6.191; P = 0.02) and cranial nerve deficit (OR = 2.946; 95 %CI, 1.562-5.557; P = 0.001). And the translabyrinthine approach group was associated with a higher total resection rate (OR = 0.246; 95 %CI (0.071-0.848); P = 0.026). However, no statistic differences were found in the incidence of the near total (OR = 0.751; P = 0.351), subtotal resection (OR = 3.664; P = 0.109), postoperative facial nerve dysfunctions (OR, 0.763; P = 0.626), postoperative meningitis (OR = 2.7; P = 0.279), cerebrospinal fluid leak (OR = 1.225; P = 0.777), postoperative headache (OR = 1.412; P = 0.339), ophthalmic complications (OR = 0.87; P = 0.59), and vascular complications (OR = 2.501; P = 0.139). CONCLUSION: Based on current evidence, the translabyrinthine approach was associated with a higher rate of total resection and a lower rate of the tinnitus and cranial nerve deficit. But the risk of cranial nerve deficit was clearly affected by the preoperative status. And a translabyrintine approach could imply a complete sensorineural hearing loss, which contribute to the lower rate of postoperative tinnitus. Consequently, more evidence-based researches are needed to supplement this opinion.


Asunto(s)
Craneotomía/métodos , Neuroma Acústico/cirugía , Hueso Occipital/cirugía , Complicaciones Posoperatorias/etiología , Vestíbulo del Laberinto/cirugía , Pérdida de Líquido Cefalorraquídeo/epidemiología , Pérdida de Líquido Cefalorraquídeo/etiología , Traumatismos del Nervio Craneal/epidemiología , Traumatismos del Nervio Craneal/etiología , Cefaleas Secundarias/epidemiología , Cefaleas Secundarias/etiología , Humanos , Incidencia , Meningitis/epidemiología , Meningitis/etiología , Estudios Observacionales como Asunto , Complicaciones Posoperatorias/epidemiología , Ensayos Clínicos Controlados Aleatorios como Asunto , Acúfeno/epidemiología , Acúfeno/etiología , Resultado del Tratamiento , Enfermedades Vasculares/epidemiología , Enfermedades Vasculares/etiología , Trastornos de la Visión/epidemiología , Trastornos de la Visión/etiología
5.
Rev Neurol ; 68(11): 453-458, 2019 Jun 01.
Artículo en Español | MEDLINE | ID: mdl-31132134

RESUMEN

INTRODUCTION: Alarm criteria make it possible to identify persons who visit emergency services because of severe secondary headaches. AIMS: To determine the socio-demographic characteristics of the patients who visit emergency departments due to headache, the incidence of alarm criteria, treatment and the diagnosis after one year's follow-up. PATIENTS AND METHODS: We conducted a retrospective observational cross-sectional study of the persons attended in the emergency department of the Arnau de Vilanova Hospital between June 2014 and May 2015 due to headache. RESULTS: A total of 303 persons were identified, of whom 165 were finally included in the study. There was a predominance of women (66.7%). The mean age was 41.2 ± 15.9 years. Only 16.4% were referred from primary care and 52 (31.5%) presented alarm criteria. A computerised tomography head scan was performed in half of these cases, and lumbar puncture was carried out in four of them (7.7%). A serious cause of headache was found in four cases (2.4%). After one year of follow-up, three patients who did not initially visit because of alarm criteria were diagnosed with severe diseases of the central nervous system, and 23 (13.9%) returned to the emergency department for the same reason. CONCLUSIONS: Only one out of every two patients meets the alarm criteria. The proportion of severe secondary headache is really low. The multidisciplinary management of headache needs to be improved in our setting to prevent people visiting the emergency department due to primary headaches without any alarm criteria.


TITLE: Incidencia de criterios de alarma y actitud frente a los pacientes con cefalea atendidos en urgencias.Introduccion. Los criterios de alarma permiten identificar a las personas que consultan por cefaleas secundarias graves en los servicios de urgencias. Objetivo. Determinar las caracteristicas sociodemograficas de los pacientes que acuden a urgencias por cefalea, la incidencia de criterios de alarma, el tratamiento y el diagnostico tras un año de seguimiento. Pacientes y metodos. Estudio transversal retrospectivo y observacional de personas atendidas en el servicio de urgencias del Hospital Arnau de Vilanova entre junio de 2014 y mayo de 2015 por cefalea. Resultados. Se identifico a un total de 303 personas, de las cuales 165 se incluyeron finalmente en el estudio. Hubo un predomino de mujeres (66,7%). La edad media fue de 41,2 ± 15,9 años. Solo un 16,4% fue derivado desde atencion primaria y 52 (31,5%) presentaban criterios de alarma. En la mitad de estos casos se realizo una tomografia computarizada craneal, y en 4 (7,7%), una puncion lumbar. Se identifico una causa grave de la cefalea en 4 casos (2,4%). Tras un año de seguimiento, tres pacientes que inicialmente no consultaron por criterios de alarma fueron diagnosticados de enfermedades graves del sistema nervioso central, y 23 (13,9%) volvieron a urgencias por el mismo motivo. Conclusiones. Solo uno de cada dos pacientes cumple criterios de alarma. La proporcion de cefalea secundaria grave es realmente baja. Es necesario mejorar el abordaje multidisciplinar de la cefalea en nuestro ambito para evitar la consulta a urgencias por cefaleas primarias sin criterios de alarma.


Asunto(s)
Actitud del Personal de Salud , Servicio de Urgencia en Hospital , Cefaleas Secundarias/diagnóstico , Evaluación de Síntomas/normas , Adulto , Neoplasias Encefálicas/complicaciones , Neoplasias Encefálicas/diagnóstico , Estudios Transversales , Femenino , Estudios de Seguimiento , Cefaleas Secundarias/epidemiología , Cefaleas Secundarias/etiología , Humanos , Incidencia , Masculino , Meningitis/complicaciones , Meningitis/diagnóstico , Persona de Mediana Edad , Recurrencia , Estudios Retrospectivos , Sinusitis/complicaciones , Sinusitis/diagnóstico , España/epidemiología , Tomografía Computarizada por Rayos X , Adulto Joven
6.
Acta Neurol Scand ; 138(6): 515-522, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30107027

RESUMEN

OBJECTIVES: Patients with chronic migraine (CM) display a considerable amount of comorbidities, particularly psychiatric and cardiovascular, and the presence of multiple comorbidities, that is, the so-called multimorbidity, is a risk factor for migraine chronification or maintenance of CM. Our aim was to address the rate and impact of multimorbidity in patients with CM and medication overuse headache (MOH). MATERIALS & METHODS: In a sample of patients with CM attending a structured withdrawal for coexisting MOH, we defined multimorbidity as the presence of two or more conditions in addition to CM-MOH. We compared patients with and without multimorbidity for demographic and clinical variables, quality of life, and disability; we also tested whether patients with multimorbidity had higher likelihood to attend emergency room, relapse into CM, and require further withdrawal treatments by 12 months. RESULTS: One hundred and ninety-four patients were enrolled as follows: 61% had at least one comorbidity, the most common being mental (34%), circulatory (18%), and endocrine conditions (13%); 32% were multimorbidity cases. Patients with multimorbidity had higher headaches frequency, older age, lower education and lower employment rates, higher disability and lower QoL. They were more frequently opioids/barbiturates overusers and were more likely to attend ER (OR: 2.36), relapse into CM (OR: 2.19), and undergo another withdrawal (OR: 2.75) by 12 months after discharge, after controlling for age, gender, years of education, and headache frequency. CONCLUSIONS: Recognizing multimorbidity in patients with CM-MOH is important to enhance the management of these complex patients, who are at risk of polypharmacy and increased health care utilization.


Asunto(s)
Cefaleas Secundarias/epidemiología , Trastornos Migrañosos/epidemiología , Multimorbilidad , Adulto , Enfermedad Crónica , Femenino , Humanos , Masculino , Persona de Mediana Edad , Calidad de Vida , Factores de Riesgo
7.
Curr Neurol Neurosci Rep ; 18(9): 61, 2018 07 30.
Artículo en Inglés | MEDLINE | ID: mdl-30058035

RESUMEN

INTRODUCTION: Headaches are a common occurrence in childhood and adolescence. Most children presenting with a chief complaint of headache have a self-limited infectious disorder or primary headache syndrome that should not require extensive workup. PURPOSE OF REVIEW: Differentiating these conditions from other more serious causes of headache in children can sometimes be difficult. This article aims to provide information regarding "red flags" that should indicate a need for concern for disorders that require more urgent evaluation. RECENT FINDINGS: Long-held beliefs about specific "red flags" that have been analyzed in recent years as to their validity and new criteria for the diagnosis of idiopathic intracranial hypertension have been elaborated based on study. These publications are reviewed in this article. Knowledge of past and current literature on secondary headache in children, combined with thorough history taking and examination, should help determine when there is concern for a serious secondary cause for headache in children and adolescents and direct workup.


Asunto(s)
Cefaleas Secundarias/diagnóstico por imagen , Cefaleas Secundarias/fisiopatología , Seudotumor Cerebral/diagnóstico por imagen , Seudotumor Cerebral/fisiopatología , Adolescente , Niño , Diagnóstico Diferencial , Cefaleas Primarias/diagnóstico por imagen , Cefaleas Primarias/epidemiología , Cefaleas Primarias/fisiopatología , Cefaleas Secundarias/epidemiología , Humanos , Seudotumor Cerebral/epidemiología
8.
J Headache Pain ; 19(1): 38, 2018 May 24.
Artículo en Inglés | MEDLINE | ID: mdl-29797100

RESUMEN

BACKGROUND: The MAST Study is a longitudinal, cross-sectional survey study of US adults with migraine. These analyses were conducted to estimate rates of acute medication overuse (AMO) and determine associations of AMO with individual and headache characteristics. METHODS: Eligible respondents had ICHD-3-beta migraine, reported ≥3 monthly headache days (MHDs) in the past 3 months, ≥1 MHD in the past 30 days, and currently took acute headache medication. AMO was defined according to ICHD-3-beta thresholds for monthly days of medication taking when diagnosing medication overuse headache. RESULTS: Eligible respondents (N = 13,649) had a mean age of 43.4 ± 13.6 years; most were female (72.9%) and Caucasian (81.9%). Altogether, 15.4% of respondents met criteria for AMO. Compared with those not overusing medications, respondents with AMO were significantly more likely to be taking triptans (31.3% vs 14.2%), opioids (23.8% vs 8.0%), barbiturates (7.8% vs 2.7%), and ergot alkaloids (3.1% vs 0.6%) and significantly less likely to be taking NSAIDs (63.3% vs 69.8%) (p < 0.001 for all comparisons). Respondents with AMO had significantly more MHDs (12.9 ± 8.6 vs 4.3 ± 4.3, p  <  0.001); higher migraine symptom severity (17.8 ± 2.7 vs 16.4 ± 3.0, p  <  0.001), higher pain intensity scores (7.4 vs 6.5, p  <  0.001); and higher rates of cutaneous allodynia (53.7% vs 37.5%, p  <  0.001). Adjusted for MHDs, the odds of AMO were increased by each additional year of age (OR 1.02, 95% CI 1.02, 1.03); being married (OR 1.19, 95% CI 1.06, 1.34); smoking (OR 1.54, 95% CI 1.31, 1.81); having psychological symptoms (OR 1.62, 95% CI 1.43, 1.83) or cutaneous allodynia (OR 1.22, 95% CI 1.08, 1.37); and greater migraine symptom severity (OR 1.06, 95% CI 1.04, 1.09) and pain intensity (OR 1.27, 95% CI 1.22, 1.32). Cutaneous allodynia increased the risk of AMO by 61% in males (OR 1.61, 95% CI 1.28, 2.03) but did not increase risk in females (OR 1.08, 95% CI 0.94, 1.25). CONCLUSIONS: AMO was present in 15% of respondents with migraine. AMO was associated with higher symptom severity scores, pain intensity, and rates of cutaneous allodynia. AMO was more likely in triptan, opioid, and barbiturate users but less likely in NSAID users. Cutaneous allodynia was associated with AMO in men but not women. This gender difference merits additional exploration.


Asunto(s)
Trastornos Migrañosos/tratamiento farmacológico , Trastornos Migrañosos/epidemiología , Uso Excesivo de Medicamentos Recetados/efectos adversos , Uso Excesivo de Medicamentos Recetados/tendencias , Encuestas y Cuestionarios , Adolescente , Adulto , Anciano , Analgésicos Opioides/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Estudios Transversales , Femenino , Cefaleas Secundarias/diagnóstico , Cefaleas Secundarias/tratamiento farmacológico , Cefaleas Secundarias/epidemiología , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Trastornos Migrañosos/diagnóstico , Factores Sexuales , Sumatriptán/uso terapéutico , Resultado del Tratamiento , Triptaminas/uso terapéutico , Adulto Joven
9.
Pediatr Int ; 60(6): 576-580, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29608810

RESUMEN

BACKGROUND: The aim of this study was to investigate the prevalence of menstruation-related headache and the impact of associated factors in adolescents. METHODS: This cross-sectional study was conducted in seven randomly selected high schools, and 3,886 girls attending those schools were invited to take part. After the consent of the school principals, a final total of 2,485 girls (63.9%) were involved in the study. A specific questionnaire was distributed to adolescent girls (14-19 years old). The first part of the survey investigated the features of menstruation (age at first menstruation, duration of period, pad fully soaked per day). The last part of the questionnaire surveyed the presence of headache during the menstrual period. The severity of headache was measured using a visual analog scale. Last, participants were requested to complete the Beck Depression Inventory (BDI). The prevalence of menstruation-related headache and associated factors were studied. RESULTS: Mean subject age was 15.89 ± 1.07 years (range, 14-19 years) and mean age at menarche was 12.96 ± 1.09 years old. The prevalence of menstruation-related headache was 25.9% (n = 646). Onset of menstruation at <12 years of age, longer duration of menstruation period, dysmenorrhea, daily consumption of coffee and cola and smoking significantly affected the frequency of menstruation-related headache. Mean BDI score was 21.68 ± 13.65 and was significantly associated with menstruation headache. CONCLUSION: Menstruation-related headache is a common problem in adolescent girls. It might be associated with different comorbidities such as depression. Accordingly, a multidisciplinary treatment approach must be considered to improve the quality of life.


Asunto(s)
Cefaleas Secundarias/epidemiología , Trastornos de la Menstruación/epidemiología , Adolescente , Estudios Transversales , Femenino , Cefaleas Secundarias/diagnóstico , Cefaleas Secundarias/etiología , Humanos , Trastornos de la Menstruación/diagnóstico , Trastornos de la Menstruación/etiología , Prevalencia , Factores de Riesgo , Autoinforme , Índice de Severidad de la Enfermedad , Turquía/epidemiología , Adulto Joven
10.
Neurol India ; 65(1): 64-68, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28084240

RESUMEN

BACKGROUND: The nervous system is among the most frequent and serious targets of human immunodeficiency virus (HIV) infection. The infection usually occurs in patients with profound immunosuppression. In 10 - 20% of the patients, the presence of a neurological disease is the first manifestation of symptomatic HIV infection. AIMS AND OBJECTIVE: Despite the wide prevalence of neurological manifestations in HIV, there is no study examining the clinical manifestations of this disease in the resource- limited communities from north-eastern parts of India. To characterize the neurological involvement in patients with HIV infection at a tertiary care institute in northeast India, we studied various neurological presentations of HIV. SETTING AND DESIGN: This was a retrospective observational study done at a tertiary care institute in northeast India over a period of 6 years from August 2008 to September 2014. MATERIAL AND METHODS: A total of 91 HIV seropositive patients of both genders, aged >18 years, showing clinical evidence of central nervous system (CNS) involvement, and admitted in a tertiary care institute were included. Their clinical manifestations, laboratory investigations, and imaging were studied. RESULT: Tuberculous meningitis was the most common presentation as secondary CNS illness (43.9%), followed by cryptococcal meningitis (14.2%) and cerebrovascular accidents (5.49%). Furthermore, 6.59% had neurosyphilis, 6.59% had acquired immune deficiency syndrome (AIDS) - associated dementia, and peripheral neuropathy occurred in 16.4% of the patients. Headache was the most common neurological symptom seen in 25% of the patients. Seizures were noted in 25% of the pateints. CD4 was significantly low in most of the patients with progressive multifocal leukoencephalopathy, HIV associated encephalopathy (HAD) and cryptococcal meningitis compared with other neurological manifestations. CD4 counts in tuberculous meningitis and HAD were 110.3/µl and 95/µl, respectively. CONCLUSION: CNS tuberculosis was the most common secondary infection seen in HIV patients followed by cryptococcal meningitis. A high index of clinical suspicion of neurological involvement in HIV patients helps in the early diagnosis and early institution of specific treatment, which in turn decreases the morbidity and mortality considerably.


Asunto(s)
Infecciones por VIH/complicaciones , Cefaleas Secundarias/etiología , Meningitis Criptocócica/etiología , Convulsiones/etiología , Tuberculosis Meníngea/etiología , Complejo SIDA Demencia/epidemiología , Complejo SIDA Demencia/etiología , Adulto , Trastornos Cerebrovasculares/epidemiología , Trastornos Cerebrovasculares/etiología , Femenino , Infecciones por VIH/epidemiología , Cefaleas Secundarias/epidemiología , Humanos , India/epidemiología , Masculino , Meningitis Criptocócica/epidemiología , Persona de Mediana Edad , Neurosífilis/epidemiología , Neurosífilis/etiología , Enfermedades del Sistema Nervioso Periférico/epidemiología , Enfermedades del Sistema Nervioso Periférico/etiología , Estudios Retrospectivos , Convulsiones/epidemiología , Centros de Atención Terciaria , Tuberculosis Meníngea/epidemiología , Adulto Joven
11.
Cephalalgia ; 36(1): 15-28, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25804645

RESUMEN

AIM: This cross-sectional study investigated associations between chronic headache (CH) with and without medication overuse, healthy lifestyle behaviour, and stress. METHODS: Questionnaires were sent to 129,150 adults. Those with headache ≥15 days per month for three months were classified as having CH then further described as having medication-overuse headache (MOH) or CH without medication overuse. Associations between headache and daily smoking, physical inactivity, obesity, excessive drinking, illicit drug use, and high stress were analysed by logistic regression. RESULTS: CH with and without medication overuse (prevalence 1.8% and 1.6%, respectively) had strong, graded associations with stress. Associations with daily smoking, physical inactivity, and obesity were significant only for MOH. Odds for MOH were highest among people who had all three factors compared to those who had none (OR 2.8 in women and 5.1 in men). High stress plus any of these three factors had synergistic effects in MOH but not clearly in those who had CH without overuse. Associations between CH subtypes and excessive drinking or illicit drug use were not statistically significant. CONCLUSION: Results suggest strong links between healthy lifestyle behaviour and stress in MOH. Stress reduction and promoting healthy behaviour are highly relevant in MOH management.


Asunto(s)
Cefaleas Secundarias/epidemiología , Trastornos de Cefalalgia/epidemiología , Conductas Relacionadas con la Salud , Encuestas Epidemiológicas , Conducta de Reducción del Riesgo , Estrés Psicológico/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Estudios Transversales , Dinamarca/epidemiología , Femenino , Trastornos de Cefalalgia/diagnóstico , Trastornos de Cefalalgia/psicología , Cefaleas Secundarias/diagnóstico , Cefaleas Secundarias/psicología , Encuestas Epidemiológicas/métodos , Humanos , Estilo de Vida , Masculino , Persona de Mediana Edad , Vigilancia de la Población/métodos , Factores de Riesgo , Estrés Psicológico/diagnóstico , Estrés Psicológico/psicología , Adulto Joven
12.
Arq. neuropsiquiatr ; Arq. neuropsiquiatr;73(11): 913-917, Nov. 2015. tab
Artículo en Inglés | LILACS | ID: lil-762885

RESUMEN

Objective The aim of this study was to estimate the prevalence of signs and symptoms of temporomandibular disorders (TMD) in patients with primary headaches attended in a tertiary neurology ambulatory.Method Authorized by the Ethics Committee, the present cross-sectional study was conducted with a random sample of patients screened for orofacial pain and primary headaches at a tertiary hospital in Northeast of Brazil.Results The sample consisted in 42 patients with primary headache, 59.5% male. The prevalence of > 6 TMD signs and symptoms was 54.8%. In those patients with migraine TMD was present in 71.4% and in tension-type headache in 38.1% (p = 0.030; OR = 4.1). TMD was related to the clinical status of headache associated or attributed to medication overuse (p = 0.001).Conclusion TMD has a high prevalence in patients with primary headaches (54.8%). Special attention must be given to patients with migraine and headache associated or attributed to medication overuse.


Objetivo Estimar a prevalência de sinais e sintomas de disfunção temporomandibular (DTM) e fatores associados em pacientes com cefaleias primárias atendidos em um ambulatório de neurologia.Método Autorizado pelo Comitê de Ética, o presente estudo transversal foi conduzido com uma amostra aleatória de pacientes investigados para dor orofacial e cefaleias primárias em um hospital terciário no nordeste do Brasil.Resultados A amostra consistiu em 42 pacientes com cefaleias primárias, sendo 59,5% homens. A prevalência de > 6 sinais e sintomas de DTM foi 54,8%. Naqueles pacientes com migrânea, DTM estava presente em 71,4% e em 38,1% daqueles com cefaleia do tipo tensional (p = 0,030; OR = 4,1). DTM foi relacionada à condição clínica de cefaleia por abuso de medicamentos (p = 0,001).Conclusão A DTM é uma condição com alta prevalência em pacientes com cefaleias primárias (54,8%). Atenção especial deve ser dada a pacientes com migrânea e cefaleia por abuso de medicamentos.


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Cefaleas Primarias/epidemiología , Trastornos de la Articulación Temporomandibular/epidemiología , Brasil/epidemiología , Estudios Transversales , Dolor Facial/epidemiología , Dolor Facial/fisiopatología , Cefaleas Primarias/fisiopatología , Cefaleas Secundarias/epidemiología , Cefaleas Secundarias/fisiopatología , Servicio Ambulatorio en Hospital , Dimensión del Dolor , Prevalencia , Distribución por Sexo , Factores Sexuales , Centros de Atención Terciaria , Trastornos de la Articulación Temporomandibular/fisiopatología
13.
Arq. neuropsiquiatr ; Arq. neuropsiquiatr;73(7): 586-592, 07/2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-752379

RESUMEN

Objective : To evaluate the use of analgesics in headache diagnosed in Outpatients Headache Clinic (ACEF), as well as his involvement in the activities of the patients. Method : 145 patients with headache seen at ACEF during the period August/July 2009/2010 underwent a questionnaire and interview with neurologist responsible for the final diagnosis according to ICHD-II. Results : Relationship Women:Men 7:1. 1) Prevalence: Migraine without aura (52.4%), migraine with aura (12.4%), chronic migraine (15.2%) and medication overuse headache (MOH) (20%). 2) Analgesic drugs used: Compounds with Dipyrone (37%), Dipyrone (23%), Paracetamol (16%) compound with Paracetamol (6%), triptans (6%) and non steroidal anti-inflammatory drugs (12%). There was a significant decrease in the duration of pain and less interference in the activities of the headache patients after the use of analgesics. Conclusion : Prevalence of MOH has been increasing in population level and specialized services. New studies emphasizing the MOH are needed to assist in the improvement of their diagnostic and therapeutic approach. .


Objetivo : Avaliar a utilização de analgésicos nas cefaleias diagnosticadas no Ambulatório de Cefaleias (ACEF), bem como a sua intervenção nas atividades dos pacientes. Método : 145 pacientes com cefaleia atendidos no ACEF durante o período entre Agosto/2009 a Julho/2010 foram submetidos a um questionário e à entrevista com médico neurologista responsável pelo diagnóstico final, segundo a ICHD-II. Resultados : Relação Mulheres:Homens de 7:1. 1) Prevalência: Migrânea sem aura (52,4%), migrânea com aura (12,4%), migrânea crônica (15,2%) e CEM (20%). 2) Analgésicos utilizados: Compostos com Dipirona (37%), Dipirona (23%), Paracetamol (16%), compostos com Paracetamol (6%), triptanos (6%) e drogas antiinflamatórias esteroidais (12%). Houve uma diminuição significativa da duração da dor e menor interferência da cefaleia nas atividades dos pacientes após o uso dos analgésicos. Conclusão : Prevalência da cefaleia por uso excessivo de medicamento (CEM) vem aumentando em nível populacional e em serviços especializados. Novos estudos enfatizando a CEM são necessários para auxiliar na melhora da sua abordagem diagnóstica e terapêutica. .


Asunto(s)
Adolescente , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Analgésicos/uso terapéutico , Cefaleas Secundarias/epidemiología , Trastornos Migrañosos/tratamiento farmacológico , Trastornos Migrañosos/epidemiología , Brasil/epidemiología , Enfermedad Crónica , Actividades Recreativas , Dimensión del Dolor , Clínicas de Dolor/estadística & datos numéricos , Calidad de Vida , Automedicación , Distribución por Sexo , Encuestas y Cuestionarios , Factores de Tiempo , Trabajo
14.
Eur J Neurol ; 22(8): 1228-34, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25981360

RESUMEN

BACKGROUND AND PURPOSE: Migraine and metabolic syndrome have been reported to coexist to a marked degree, especially in women migraine patients, but the relationship between these two conditions is still unclear. This study was performed to evaluate the association of headache characteristics and its comorbidities with metabolic syndrome (MetS) and its components in female migraine patients. METHODS: A total of 142 women with migraine who fulfilled the criteria of the International Classification of Headache Disorders 2nd edition were recruited in a neurological outpatient department in China. The characteristics of migraine and its comorbidities (analgesic use, psychiatric disorders and disability) were assessed with a detailed questionnaire. Anthropometrics, blood biochemistry and transcranial Doppler sonography were used for metabolic measurements and vascular function. RESULTS: Of 142 participants, 70.4% had one or more metabolic abnormalities and 12.0% had MetS. After adjustment for age, residence, body mass index, waist-to-height ratio, smoking and drinking history, chronic migraine in women patients was associated with MetS [odds ratio (OR) = 5.342, P = 0.032], but when the chronic migraine patients were comorbid with medication overuse headache (MOH), the risk for MetS increased significantly (OR = 12.68, P = 0.007). In addition, MOH was associated with abdominal obesity and hypertension amongst the components of MetS (OR = 4.205 and 3.234, P = 0.043 and 0.039, respectively). CONCLUSIONS: Our study may suggest that chronic migraine is associated with MetS, especially when it is comorbid with analgesic overuse. MOH may be the risk factor for MetS in female migraine patients and associated with abdominal obesity and hypertension.


Asunto(s)
Analgésicos/efectos adversos , Cefaleas Secundarias/epidemiología , Síndrome Metabólico/epidemiología , Trastornos Migrañosos/epidemiología , Adulto , China/epidemiología , Comorbilidad , Femenino , Cefalea/epidemiología , Cefaleas Secundarias/inducido químicamente , Humanos , Hipertensión/epidemiología , Persona de Mediana Edad , Obesidad Abdominal/epidemiología , Factores de Riesgo
15.
Acta Clin Croat ; 52(3): 281-8, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24558758

RESUMEN

The aim of this study was to analyze the management of headache patients presenting to the emergency room (ER) at a university hospital in Zagreb. Retrospective analysis of all patients with headache was carried out during 2007. Patients were analyzed according to the diagnoses, diagnostic procedures, treatment and further referral. Among 6225 patients, 1385 (22.3%) complained of headache; there were 894 (64.5%) women and 491 (35.5%) men. Migraine with or without aura, tension-type headache or "cervicogenic headache" had 1004 (72.5%) patients (women 67.5% and men 32.5%); secondary headache had 381 (27.5%) patients: 89 (6.4%) stroke or intracranial hemorrhage, 33 (2.4%) primary tumor, 54 (3.9%) metastatic tumor, 200 (14.4%) head trauma with or without hemorrhage, and 5 (0.4%) had an infectious disease. Diagnostic procedure was performed in 413 (29.8%) patients: 314 (22.7%) underwent computerized tomography scan of the brain, 85 (6.1%) electroencephalography and 70 (5%) ultrasound examination. Nonsteroidal antiinflammatory drugs (NSAIDs) and diazepam were the most commonly prescribed medications, followed by fluids, simple analgesics and antiemetics, whereas opioids were prescribed to 3.0% of patients. Among patients with primary headaches, diagnostic procedure was performed in 235 (23.2%) patients, while 40 (4.0%) patients were hospitalized. In conclusion, one-fifth of the patients presenting to neurological ER complain of headache and approximately three-quarters have primary headache. The majority of patients are treated with NSAIDs and a minority with opioids. Better treatment for these patients should be provided by general practitioners and neurologists in outpatient headache clinics.


Asunto(s)
Servicio de Urgencia en Hospital , Cefaleas Primarias/diagnóstico , Cefaleas Primarias/terapia , Cefaleas Secundarias/diagnóstico , Cefaleas Secundarias/terapia , Adulto , Analgésicos/uso terapéutico , Croacia , Ecoencefalografía , Electroencefalografía , Femenino , Cefaleas Primarias/epidemiología , Cefaleas Secundarias/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Derivación y Consulta , Estudios Retrospectivos , Tomografía Computarizada por Rayos X
16.
Rev. Assoc. Med. Bras. (1992, Impr.) ; Rev. Assoc. Med. Bras. (1992, Impr.);58(6): 709-713, nov.-dez. 2012. tab
Artículo en Portugués | LILACS | ID: lil-659821

RESUMEN

OBJETIVO: Avaliar a frequência dos diferentes diagnósticos de cefaleias do Ambulatório de Cefaleias do Hospital das Clínicas da Universidade Federal de Minas Gerais (AmbCef-UFMG). MÉTODOS: Estudo transversal e descritivo com 289 pacientes atendidos consecutivamente no AmbCef-UFMG. O diagnóstico da cefaleia baseou-se nos critérios da Classificação Internacional das Cefaleias (ICDH-2004). RESULTADOS: A idade média dos pacientes foi 42,6 anos, sendo a maioria do sexo feminino (86,9%) e com menos de nove anos de escolaridade. As cefaleias primárias foram as mais comuns, sendo a migrânea encontrada em 79,8% dos casos e a cefaleia do tipo tensional (CTT), em 20,4%. Entre as secundárias, o tipo mais comum foi a cefaleia por uso excessivo de analgésicos (16,6%), seguido de casos menos comuns como a hipertensão intracraniana idiopática. A cefaleia crônica diária (CCD) esteve presente em 31,8% dos casos. CONCLUSÃO: Este estudo confirma dados da literatura que mostram a migrânea como a cefaleia mais comum em centros terciários. O número expressivo de casos de CCD e de uso excessivo de analgésicos indica que, desde o nível primário de atenção, os pacientes deveriam ser orientados a evitar o uso abusivo de medicação sintomática.


OBJECTIVE: To assess the frequency of different diagnoses of headaches in the Headache Outpatient Clinic of the Hospital das Clínicas of the Universidade Federal de Minas Gerais (AmbCef-UFMG). METHODS: Cross sectional study with 289 patients consecutively attended to at AmbCef-UFMG. Headaches were diagnosed based on the criteria established by the International Classification of Headache Disorders (ICDH-2004). RESULTS: The average age of patients was 42.6 years, mostly women (86.9%) with less than nine years of education. Primary headaches were the most common type, with migraine found in 79.8% of cases, and tension-type headache (TTH) in 20.4%. Among the secondary types, the most common was headache caused by overuse of analgesics (16.6%), followed by less common types, such as idiopathic intracranial hypertension. Chronic daily headache (CDH) was found in 31.8% of cases. CONCLUSION: This study confirms literature data showing migraine as the most common headache in tertiary care centers. The expressive number of cases of CDH and headaches caused by overuse of analgesics indicates that, starting at the primary care level, patients should be advised to avoid the abuse of symptomatic drugs.


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Trastornos de Cefalalgia/diagnóstico , Instituciones de Atención Ambulatoria , Brasil/epidemiología , Estudios Transversales , Diagnóstico Diferencial , Cefaleas Secundarias/diagnóstico , Cefaleas Secundarias/epidemiología , Trastornos de Cefalalgia/epidemiología , Trastornos Migrañosos/diagnóstico , Trastornos Migrañosos/epidemiología , Cefalea de Tipo Tensional/diagnóstico , Cefalea de Tipo Tensional/epidemiología , Centros de Atención Terciaria/estadística & datos numéricos
17.
Rev Neurol ; 54 Suppl 2: S13-9, 2012 Apr 10.
Artículo en Español | MEDLINE | ID: mdl-22532238

RESUMEN

Chronic migraine is considered a complication of episodic migraine. Several risk factors, which may be modifiable or non-modifiable, make varying contributions to the progression towards chronification. Every year 2.5% of patients with episodic migraine go on to suffer chronic migraine. Experimental studies point to a dysfunction in the descending pain modulatory system that would facilitate nociceptive afferents, in the absence of damage to tissues, and so chronic migraine would share a pathogenesis that is similar to that of fibromyalgia, irritable bowel syndrome or chronic tension-type headache (conditions that frequently coexist). This paper reviews the risk factors and the scientific evidence of the possible pathogenic mechanisms involved in the progression towards chronification.


Asunto(s)
Trastornos Migrañosos/fisiopatología , Encéfalo/patología , Encéfalo/fisiopatología , Enfermedad Crónica , Comorbilidad , Fibromialgia/epidemiología , Fibromialgia/fisiopatología , Foramen Oval Permeable/complicaciones , Foramen Oval Permeable/epidemiología , Foramen Oval Permeable/fisiopatología , Cefaleas Secundarias/epidemiología , Cefaleas Secundarias/etiología , Humanos , Hiperalgesia/epidemiología , Hiperalgesia/fisiopatología , Inflamación/epidemiología , Inflamación/fisiopatología , Embolia Intracraneal/etiología , Embolia Intracraneal/fisiopatología , Síndrome del Colon Irritable/epidemiología , Síndrome del Colon Irritable/fisiopatología , Trastornos Migrañosos/epidemiología , Trastornos Migrañosos/etiología , Trastornos del Humor/epidemiología , Trastornos del Humor/fisiopatología , Neuroimagen , Obesidad/epidemiología , Obesidad/fisiopatología , Percepción del Dolor , Hormonas Peptídicas/fisiología , Prevalencia , Factores de Riesgo , Síndromes de la Apnea del Sueño/epidemiología , Síndromes de la Apnea del Sueño/fisiopatología , Sistema Nervioso Simpático/fisiopatología , Nervio Trigémino/fisiopatología
18.
Pain ; 153(1): 56-61, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22018971

RESUMEN

Medication-overuse headache (MOH) is relatively common, but its incidence has not been calculated and there are no prospective population-based studies that have evaluated risk factors for developing MOH. The aim of this study was to estimate incidences of and identify risk factors for developing chronic daily headache (CDH) and MOH. This longitudinal population-based cohort study used data from the Nord-Trøndelag Health Surveys performed in 1995-1997 and 2006-2008. Among the 51,383 participants at baseline, 41,766 were eligible approximately 11 years later. There were 26,197 participants (responder rate 63%), among whom 25,596 did not report CDH at baseline in 1995-1997. Of these, 201 (0.8%) had MOH and 246 (1.0%) had CDH without medication overuse (CDHwoO) 11 years later. The incidence of MOH was 0.72 per 1000 person-years (95% confidence interval 0.62-0.81). In the multivariate analyses, a 5-fold risk for developing MOH was found among individuals who at baseline reported regular use of tranquilizers [odds ratio 5.2 (3.0-9.0)] or who had a combination of chronic musculoskeletal complaints, gastrointestinal complaints, and Hospital Anxiety and Depression Scale score ≥ 11 [odds ratio 4.7 (2.4-9.0)]. Smoking and physical inactivity more than doubled the risk of MOH. In contrast, these factors did not increase the risk of CDHwoO. In this large population-based 11-year follow-up study, several risk factors for MOH did not increase the risk for CDHwoO, suggesting these are pathogenetically distinct. If the noted associations are causal, more focus on comorbid condition, physical activity, and use of tobacco and tranquilizers may limit the development of MOH.


Asunto(s)
Analgésicos/efectos adversos , Cefaleas Secundarias/epidemiología , Adulto , Anciano , Femenino , Estudios de Seguimiento , Cefaleas Secundarias/inducido químicamente , Humanos , Incidencia , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Noruega/epidemiología , Prevalencia , Factores de Riesgo
19.
Curr Pain Headache Rep ; 15(4): 295-301, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21455737

RESUMEN

Prevalence of headache lowers with age, and headaches of elderly adults tend to be different than those of the younger population. Secondary headaches, such as headaches associated with vascular disease, head trauma, and neoplasm, are more common. Also, certain headache types tend to be geriatric disorders, such as primary cough headache, hypnic headache, typical aura without headache, exploding head syndrome, and giant cell arteritis. This review provides an overview of some of the major and unusual geriatric headaches, both primary and secondary.


Asunto(s)
Anciano/estadística & datos numéricos , Trastornos de Cefalalgia/epidemiología , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Epilepsia/epidemiología , Arteritis de Células Gigantes/complicaciones , Cefaleas Primarias/epidemiología , Cefaleas Primarias/terapia , Cefaleas Secundarias/inducido químicamente , Cefaleas Secundarias/epidemiología , Cefaleas Secundarias/terapia , Humanos , Trastornos Migrañosos
20.
Curr Pain Headache Rep ; 15(4): 324-31, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21465114

RESUMEN

Cervicogenic headache (CeH) is a relatively common syndrome. The paroxysmal and rather intense head pain usually is unilateral, spreading from the back of the head to the frontal and temporal regions, and triggered by certain movements or sustained provocative head positions. Digital pressure over triggering areas at the upper nuchal area reproduces the spontaneous pain pattern. Available clinical criteria differentiate this picture from other headache disorders, although superposition may be present in some cases. The neck is involved with other pain disorders apart from CeH. Migraine may be induced by cervical trigger factors in some cases, and whiplash lesions produce CeH-like symptoms as well as others. Occipital neuralgia refers to pain restricted to the distribution of the affected nerve and should not be mistaken as CeH. There is no definite, universal treatment for CeH yet. Options include physical therapy, preventive medicines, anesthetic blocks, denervation procedures, and surgery. The treatment choice must be performed on individual basis.


Asunto(s)
Cefaleas Secundarias/etiología , Dolor de Cuello/complicaciones , Diagnóstico Diferencial , Cefaleas Secundarias/diagnóstico , Cefaleas Secundarias/epidemiología , Cefaleas Secundarias/fisiopatología , Cefaleas Secundarias/terapia , Humanos , Traumatismos del Cuello/complicaciones , Dolor de Cuello/diagnóstico , Dolor de Cuello/epidemiología , Dolor de Cuello/fisiopatología , Dolor de Cuello/terapia , Lesiones por Latigazo Cervical/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA